Nintendo’s (OTCPK:NTDOY) new Switch console is launching around the globe this month.
This is the time for many investors to reconsider Nintendo as an investment as I first did back in 2014, then comparing it to Sony and its PlayStation unit (when the stock valuations resulted in a similar market cap for both companies).
I leave the detailed reviews of Nintendo’s new Switch hardware and software to specialized sites and will just quote a summary:
Compared to the Wii U on its merits, the Switch is a slam dunk. It takes the basic concept of the Wii U, of a tablet-based console, and fulfills the promise of it in a way Nintendo simply wasn’t capable of realizing in 2012. It’s launching with a piece of software that, more than anything in the Wii U’s first year, demonstrates its inherent capability of delivering what Nintendo says is one of the Switch’s primary missions: a big-budget, AAA game that exists across a handheld device and a television-connected portable. The hardware lives up to its name in how easily and smoothly it moves between those two worlds, in how dead simple it all is to make something pretty magical happen.
hot stocks to buy: Array BioPharma Inc.(ARRY)
Advisors’ Opinion:
- [By Lisa Levin]
Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).
- [By Lisa Levin] Gainers
Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
Sorl Auto
hot stocks to buy: C.H. Robinson Worldwide, Inc.(CHRW)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.
- [By Chad Tracy]
As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.
Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.
- [By Gary Jakacky]
Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).
If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.
hot stocks to buy: Cidara Therapeutics, Inc.(CDTX)
Advisors’ Opinion:
- [By Lee Jackson]
These companies also reported insider buying last week: Cidara Therapeutics Inc. (NASDAQ: CDTX), Ducommun Inc. (NYSE: DCO), HealthEquity Inc. (NASDAQ: HQY), Panhandle Oil and Gas Inc. (NYSE: PHX) and PolarityTE Inc. (NASDAQ: COOL).
hot stocks to buy: Pinnacle Entertainment Inc.(PNK)
Advisors’ Opinion:
- [By Ben Levisohn]
Pinnacle Entertainment (PNK) has gained 56% this year; Las Vegas Sands (LVS) has climbed 38%. And Deutsche Bank has nice things to say about both today.
Bloomberg
First Pinnacle. Deutsche Bank’s Carlo Santarelli ponders the stock’s big move and comes away still seeing value in its shares. He writes:
When we upgraded PNK in April, our thesis centered on the FCF strength of the combined entities [Pinnacle completed its acquisition of Ameristar Casinos on Aug. 14], a handful of favorable catalysts, easing regional gaming comps, & an inexpensive relative valuation. Given the shares’ sizeable move since then, we believe it is worth revisiting the investment case. Post the announcement of several asset sales and the closing of the transaction, we are adjusting our estimates, raising our PT to $30 from $24, and maintaining our bullish view at current levels given what we still believe to be an attractive free cash flow valuation, meaningful potential synergy realization beyond the $40 mm of announced benefits, and a free option on a lagging regional recovery.
Santarelli also revisited Las Vegas Sands and there too, he likes what he sees. He writes:
With…LVS at [a share price level] that have been challenging to break from over the last year plus, we believe this time is different and hence we see continued upward momentum…In the case of LVS, we see; 1) meaningful mass market strength continuing through year end, setting the stage for upward company and market estimate revisions for 2014, 2) continued cash flow appreciation and capital returns serving as downside protection and positive catalysts, and 3) continued shared gains, largely driven by table optimization and mass market strength, driving both estimates and sentiment.
He also likes Wynn Resorts (WYNN), despite its 34% gain.Santarelli writes:
As for WYNN, we believe near-term estimates continue to take a back seat to capital return
hot stocks to buy: Snyder's-Lance, Inc.(LNCE)
Advisors’ Opinion:
- [By Monica Gerson]
Snyder’s-Lance Inc (NASDAQ: LNCE) is estimated to report its quarterly earnings at $0.23 per share on revenue of $470.33 million.
Examworks Group, Inc. (NYSE: EXAM) is projected to post its quarterly earnings at $0.08 per share on revenue of $217.47 million.
hot stocks to buy: BIG YELLOW GROUP PLC (BYLOF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
The Big Yellow Group (OTC:BYLOF) recognized this opportunity back in 1998 when it was founded and has ever since been working towards bringing new supply of self-storage properties to the UK market. The strategy resulted in the following performance:
